328 related articles for article (PubMed ID: 7370944)
21. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
Berenguer Sánchez A
Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
[No Abstract] [Full Text] [Related]
22. [Treatment of prostatic cancer].
Lehtonen T; Mäntylä M
Duodecim; 1979; 95(12):760-7. PubMed ID: 520197
[No Abstract] [Full Text] [Related]
23. Hormonal implications in the development and treatment of prostate cancer.
Ip C; Hall SJ
Endocrinol Metab Clin North Am; 2007 Jun; 36(2):421-34. PubMed ID: 17543727
[TBL] [Abstract][Full Text] [Related]
24. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
25. Maximal androgen blockade versus total androgen suppression.
Dumez H; Van Poppel H; Baert L; Paridaens R
Acta Urol Belg; 1997 Mar; 65(1):49-54. PubMed ID: 9175283
[TBL] [Abstract][Full Text] [Related]
26. [Principles for the conservative drug therapy treatment of prostate cancer].
Hofmann W
Z Urol Nephrol; 1981 Sep; 74(9):697-704. PubMed ID: 7314992
[No Abstract] [Full Text] [Related]
27. [Androgen-dependent carcinoma].
Shimazaki J; Fuse H; Akimoto S; Akakura K; Ichikawa T
Rinsho Byori; 1988 Dec; 36(12):1379-85. PubMed ID: 3249400
[No Abstract] [Full Text] [Related]
28. [Current status and problems associated with endocrine therapy of prostatic cancer].
Naito S
Fukuoka Igaku Zasshi; 1996 Feb; 87(2):41-4. PubMed ID: 8851366
[No Abstract] [Full Text] [Related]
29. [Hormone treatment of prostate carcinoma: past achievements and current perspectives].
Debruyne FM
Ned Tijdschr Geneeskd; 1986 Apr; 130(17):768-71. PubMed ID: 2423888
[No Abstract] [Full Text] [Related]
30. Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.
Nishiyama T; Suzuki K; Yamana K; Tonegawa E; Wako K; Takahashi K
Expert Rev Anticancer Ther; 2006 Feb; 6(2):259-68. PubMed ID: 16445378
[TBL] [Abstract][Full Text] [Related]
31. [Hormone therapy in advanced and generalized carcinoma of the prostate].
Vachalovský V; Dvorácek J; Voboril V
Cas Lek Cesk; 1998 Aug; 137(17):532-6. PubMed ID: 9787507
[TBL] [Abstract][Full Text] [Related]
32. Effects and metabolism of hormones in normal and neoplastic prostate tissue.
Ofner P
Vitam Horm; 1968; 26():237-91. PubMed ID: 4181431
[No Abstract] [Full Text] [Related]
33. Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense?
Schulman CC; Wildschutz TP
Acta Urol Belg; 1996 May; 64(2):57-61. PubMed ID: 8701814
[No Abstract] [Full Text] [Related]
34. Hormonal treatment of prostate cancer.
Smith S
Ir Med J; 1996; 89(2):50. PubMed ID: 8682625
[No Abstract] [Full Text] [Related]
35. Endocrine therapy of advanced carcinoma of the prostate.
Daneshgari F; Crawford ED
Cancer; 1993 Feb; 71(3 Suppl):1089-97. PubMed ID: 8428333
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic problems in hormone-dependent cancer].
Zimel H
Stud Cercet Endocrinol; 1969; 20(2):111-25. PubMed ID: 4898947
[No Abstract] [Full Text] [Related]
37. Key targets of hormone treatment of prostate cancer. Part I: the androgen receptor and steroidogenic pathways.
Pitts WR
BJU Int; 2009 Nov; 104(9):1304. PubMed ID: 19824968
[No Abstract] [Full Text] [Related]
38. Secondary hormonal therapy.
Smith DC
Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134
[TBL] [Abstract][Full Text] [Related]
39. [Prostatic cancer, diagnosis and hormonal treatment (author's transl)].
Rutishauser G
Schweiz Rundsch Med Prax; 1974 Feb; 63(5):120-3. PubMed ID: 4424280
[No Abstract] [Full Text] [Related]
40. Prostate cancer--treatment of disseminated disease.
Abi-Aad AS; Opsomer RJ
Acta Urol Belg; 1996 May; 64(2):67-76. PubMed ID: 8701817
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
